{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:22:44Z","timestamp":1793604164619,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.carrev.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T06:51:30Z","timestamp":1753426290000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study"],"prefix":"10.1016","volume":"86","author":[{"given":"Atman P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Coylewright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.07.012_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0010","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.07.012_bb0015","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.07.012_bb0020","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.4244\/EIJ-D-23-00684","article-title":"Single antiplatelet therapy following Amplatzer left atrial appendage occlusion","volume":"20","author":"Kramer","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2025.07.012_bb0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.hrthm.2024.12.007","article-title":"Single versus dual antiplatelet therapy after left atrial appendage closure: a propensity score matching analysis","volume":"22","author":"Galea","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.carrev.2025.07.012_bb0030","first-page":"S1553","article-title":"Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry","volume":"9","author":"Gallo","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2025.07.012_bb0035","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2025.07.012_bb0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcin.2023.11.027","article-title":"First experience with amulet in the United States: early insights from EMERGE LAA postapproval study","volume":"17","author":"Alkhouli","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.07.012_bb0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0055","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","article-title":"DAPT is comparable to OAC following LAAC with WATCHMAN FLX: a national registry analysis","volume":"16","author":"Coylewright","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.carrev.2025.07.012_bb0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2024.10.101","article-title":"5-year results from the AMPLATZER amulet left atrial appendage occluder randomized controlled trial","volume":"85","author":"Lakkireddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0065","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.carrev.2025.07.012_bb0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.07.012_bb0075","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis","volume":"45","author":"Samaras","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2025.07.012_bb0090","doi-asserted-by":"crossref","first-page":"e012812","DOI":"10.1161\/CIRCINTERVENTIONS.122.012812","article-title":"Antithrombotic management after left atrial appendage closure: current evidence and future perspectives","volume":"16","author":"Mesnier","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.07.012_bb0095","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2016.08.016","article-title":"Single antiplatelet therapy following left atrial appendage closure in patients with contraindication to anticoagulation","volume":"68","author":"Rodriguez-Gabella","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0110","first-page":"e013750","article-title":"Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","author":"Kapadia","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.07.012_bb0115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.07.012_bb0120","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2025.07.012_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the amulet IDE trial","volume":"9","author":"Schmidt","year":"2023","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:28:24Z","timestamp":1778819304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925003987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"alternative-id":["S1553838925003987"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.07.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}